Clinical Strategies to Achieve an Early and Successful Response to Tyrosine Kinase Inhibitor Therapy-Reference-Cited by-同舟云学术

Clinical Strategies to Achieve an Early and Successful Response to Tyrosine Kinase Inhibitor Therapy

Published:2009-04 Issue: Volume:46 Page:S11-S15
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Hughes Timothy,Hochhaus Andreas

Publisher

Elsevier BV

Subject

Hematology

Reference23 articles.

1. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

2. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O'Brien;N Engl J Med,2003

3. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

4. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia;Hughes;N Engl J Med,2003

5. Hochhaus A, O'Brien SG, Guilhot F, et al. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia. In press.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery`;Oncoscience;2023-09-20

2. Зв’язок функціональної активності клітин-попередників кісткового мозку при хронічній мієлоїдній лейкемії з індивідуальною відповіддю на терапію;Visnyk of Dnipropetrovsk University. Biology, medicine;2012-07-14

3. Combining molecular targeted therapies;Anti-Cancer Drugs;2011-09

4. Pattern of Pediatric Chronic Myeloid Leukemia in Sudan and Hematological Response to Imatinib;Pediatric Hematology and Oncology;2010-11-17

5. Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib;Clinical Pharmacology & Therapeutics;2010-03-17